Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus
- 6 September 2003
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 60 (3), 209-219
- https://doi.org/10.1016/j.antiviral.2003.07.004
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- RFI-641, a Potent Respiratory Syncytial Virus InhibitorAntimicrobial Agents and Chemotherapy, 2002
- RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion proteinChemistry & Biology, 2001
- Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivoAntiviral Research, 2000
- Nasal Cytokine and Chemokine Responses in Experimental Influenza A Virus Infection: Results of a Placebo‐Controlled Trial of Intravenous Zanamivir TreatmentThe Journal of Infectious Diseases, 1999
- Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.Journal of Clinical Investigation, 1998
- Transcriptional Induction of Multiple Cytokines by Human Respiratory Syncytial Virus Requires Activation of NF-κB and Is Inhibited by Sodium Salicylate and AspirinVirology, 1997
- Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.Proceedings of the National Academy of Sciences, 1996
- Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradientsJournal of Virological Methods, 1991
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methaneVirology, 1980